QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Enzon PharmaceuticalsSeneca BiopharmaTitan PharmaceuticalsPharmaCyte BiotechVitro Diagnostics
SymbolOTCMKTS:ENZNNASDAQ:SNCANASDAQ:TTNPOTCMKTS:PMCBOTCMKTS:VODG
Price Information
Current Price$0.46$1.11$2.88$0.02$0.40
52 Week RangeN/AN/ABuyN/AN/A
MarketRank™
Overall Score0.60.61.20.50.5
Analysis Score0.00.03.50.00.0
Community Score2.82.32.62.42.4
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.60.00.00.0
Analyst Ratings
Consensus RecommendationN/AN/ABuyN/AN/A
Consensus Price TargetN/AN/A$11.00N/AN/A
% Upside from Price TargetN/AN/A281.94% upsideN/AN/A
Trade Information
Market Cap$33.77 million$19.20 million$20.56 million$45.19 million$9.65 million
Beta0.771.830.980.492.08
Average Volume408,1853,579,1842,127,12224,424,42436,237
Sales & Book Value
Annual Revenue$210,000.00$10,000.00$3.61 millionN/AN/A
Price / Sales160.801,919.865.70N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.14 per share$1.33 per share$0.75 per shareN/AN/A
Price / Book3.250.833.84N/AN/A
Profitability
Net Income$-980,000.00$-8,350,000.00$-16,460,000.00$-3,830,000.00N/A
EPSN/AN/A($21.62)N/AN/A
Trailing P/E Ratio0.000.00N/A0.000.00
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,711.94%-230.34%-382.11%N/AN/A
Return on Equity (ROE)-20.29%-122.20%-986.16%-57.82%N/A
Return on Assets (ROA)-18.69%-110.61%-179.22%-49.63%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A2.14%N/AN/A
Current Ratio8.91%14.96%1.13%5.92%4.30%
Quick Ratio8.91%14.96%0.95%5.92%3.61%
Ownership Information
Institutional Ownership PercentageN/A5.24%N/A0.02%N/A
Insider Ownership Percentage0.03%2.11%0.46%N/A27.74%
Miscellaneous
EmployeesN/A7214N/A
Shares Outstanding74.22 million17.30 million7.14 million2.34 billion24.12 million
Next Earnings Date3/10/2021 (Estimated)3/26/2021 (Estimated)3/29/2021 (Estimated)3/12/2021 (Estimated)N/A
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.